12-O-Tetradecanoylphorbol-13-acetate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 12-O-Tetradecanoylphorbol-13-acetate, covering 2010-01-26 to 2010-01-26. Get the full timeline:
Most recent: Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]